SurgiCount Medical Announces Expanded Honor Roll Hospital Users, Landmark Product Usage Milestone... (or; and any inability to successfully pr...)

SurgiCount Medical Announces Expanded Honor Roll Hospital Users, Landmark Product Usage Milestones Achieved

Date:7/25/2011

or; and any inability to successfully protect our intellectual property portfolio. In light of the risks and uncertainties, there can be no assurance that any forward-looking statement will in fact prove to be correct.

Forward-looking statements can be affected by many other factors, including, those described in the "Business", "Management's Discussion and Analysis of Financial Condition and Results of Operations" and "Factors Affecting Future Results" sections of our Annual Report on Form 10-K for 2010, our Quarterly Reports on Form 10-Q and in our other public filings. These documents are available online through the SEC's website, www.sec.gov. Forward-looking statements are based on information presently available to senior management, and we have not assumed any duty to update any forward-looking statements.

SOURCE SurgiCount Medical, Inc.
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3
Related medicine technology :

1. Kalispell Regional Medical Center to Implement the SurgiCount Safety-Sponge® System
2. Mayo Clinic Research on SurgiCount To Be Presented at Conferences
3. SurgiCount Medical Announces the Successful Implementation of the Safety-Sponge® System at the University of Michigan Health System
4. Independent Clinical Research Confirms Clinical Efficacy and Cost-Effectiveness of the SurgiCount Safety-Sponge® System
5. Harvard Medical School-Partners HealthCare Center for Genetics and Genomics Successfully Completes Evaluation of AutoGenomics 2C9-VKORC1 Panel to Assess Warfarin Sensitivity
6. You May Have a Thyroid Problem and Not Know It - Particularly If Youre Over 60, Says a New Harvard Medical School Report
7. Harvard Medical School-Partners HealthCare Center for Genetics and Genomics Successfully Completes Evaluation of AutoGenomics 2C9-VKORC1 Panel to Assess Warfarin Sensitivity
8. Globus Medical Raises $110 Million in Series E Financing Round
9. Quark Pharmaceuticals Appoints New Chief Medical Officer
10. Boston University Biomedical Engineers Find Chink in Bacterias Armor
11. Rochester Medical Anti-Infection Foley Catheter Demonstrates Effectiveness in Randomized Trial

Post Your Comments:

(Date:6/18/2013)... Pharmaceuticals, Inc. (NASDAQ: ISIS ), the leader in ... corporate update in conjunction with its 2013 Annual Meeting of ... p.m. Pacific Time in Carlsbad, CA. ... 2:00 p.m. – 2:10 p.m. Annual Meeting of Stockholders (only ... p.m. – 3:15 p.m. Corporate Presentation – Stanley T. ...

(Date:6/17/2013)... , June 17, 2013 Vanda ... presented additional data today at ENDO 2013, the ... that tasimelteon can entrain (synchronize) both melatonin and ... to reset the master body clock and address ... Disorder (Non-24). The SET (Safety and Efficacy of ...

(Date:6/17/2013)... 17, 2013 Valeant Pharmaceuticals International, Inc. (NYSE: ... has filed a preliminary prospectus supplement to its effective shelf ... similar filing with securities regulatory authorities in each of the ... a public offering of its common shares to raise gross ... Company will also grant to the underwriters of the Offering ...

Breaking Medicine Technology:Isis Pharmaceuticals to Present a General Corporate Update at its 2013 Annual Meeting of Stockholders and Open House 2 Vanda Presents Data From Phase III Studies that Demonstrate Tasimelteon Restores Daily Cortisol Rhythm In Blind Patients With Non-24-Hour Disorder 2 Vanda Presents Data From Phase III Studies that Demonstrate Tasimelteon Restores Daily Cortisol Rhythm In Blind Patients With Non-24-Hour Disorder 3 Vanda Presents Data From Phase III Studies that Demonstrate Tasimelteon Restores Daily Cortisol Rhythm In Blind Patients With Non-24-Hour Disorder 4 Valeant Pharmaceuticals Announces Public Offering Of Common Shares 2 Valeant Pharmaceuticals Announces Public Offering Of Common Shares 3 Valeant Pharmaceuticals Announces Public Offering Of Common Shares 4

[0] Isis Pharmaceuticals to Present a General Corporate Update at its 2013 Annual Meeting of Stockholders and Open House [0] Vanda Presents Data From Phase III Studies that Demonstrate Tasimelteon Restores Daily Cortisol Rhythm In Blind Patients With Non-24-Hour Disorder [0] Valeant Pharmaceuticals Announces Public Offering Of Common Shares

... Reportlinker.com announces that a new market research report ... Global Markets for Catheters http://www.reportlinker.com/p0801348/Global-Markets-for-Catheters.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Medical_Equipment_and_Supply ... STUDY GOALS AND OBJECTIVES ... in conducting this study was to determine the present ...

... Experts from PAREXEL International Corporation (NASDAQ: ... will advise biopharmaceutical companies on how to successfully navigate ... Drug Information Association (DIA) 24th Annual EuroMeeting. The meeting ... Copenhagen, Denmark. Consultants from PAREXEL will be ...

Global Markets for Catheters PAREXEL to Address New Regulatory Guidelines and Data Standards at DIA EuroMeeting

(Date:6/19/2013)... After investing efforts for months in ... formally announced the launch of database integration for the ... latest entry in the list of extraordinary vehicles lined ... redesigned 2012 Nissan NV is all ready to get ... , Provided with two high power capable engines, the ...

(Date:6/19/2013)... Audibel Hearing Center is pleased ... patients, the A2 with Multiflex Tinnitus Technology. Tinnitus ... in the ears. Although bothersome, tinnitus usually isn’t ... , Using their patent-pending Multiflex Tinnitus Technology, the ... sound stimulus that resonates through the patient’s ear. ...

(Date:6/19/2013)... June 19, 2013 According to Vanessa ... abusers called “psychonauts” are creating new designer drugs featuring ... research of published documents and patented formulas. She reported ... & Now on June 4. , “Some of ... They’re never tested on humans. Maybe some of them ...

(Date:6/19/2013)... The Report "Data Center Security Market ... DLP, UTM, IAM, SIEM, DR, ILM); Physical Security ... Advancements, Forecasts & Analysis (2013-2018)", defines and segments ... sub-segments with in-depth analysis and forecasting of revenues. ... market with insights into trends, opportunities, and challenges. ...

(Date:6/19/2013)... Tewkesbury, UK (PRWEB) June 19, 2013 ... solutions, is sponsoring today's event, at which it will ... issues, as well as giving further insight into its ... gathering for IT & business professionals specialising in IDM ... wide range of markets including the public sector, banking, ...

Breaking Medicine News(10 mins):Health News:Rim Fitments Expert, SizeItUp Comes Up With Database Integrations For The 2012 Nissan NV 2 Health News:Audibel Hearing Center Introduces A2 with Multiflex Tinnitus Technology 2 Health News:Dangerous Designer Drugs Dodge Legal System 2 Health News:Dangerous Designer Drugs Dodge Legal System 3 Health News:Data Center Security Market is Poised to Grow at A CAGR of 16.3% & to Reach $13.77 Billion By 2018 - New Report by MarketsandMarkets 2 Health News:Data Center Security Market is Poised to Grow at A CAGR of 16.3% & to Reach $13.77 Billion By 2018 - New Report by MarketsandMarkets 3 Health News:Data Center Security Market is Poised to Grow at A CAGR of 16.3% & to Reach $13.77 Billion By 2018 - New Report by MarketsandMarkets 4

[0] Rim Fitments Expert, SizeItUp Comes Up With Database Integrations For The 2012 Nissan NV [0] Audibel Hearing Center Introduces A2 with Multiflex Tinnitus Technology [0] Dangerous Designer Drugs Dodge Legal System [0] Data Center Security Market is Poised to Grow at A CAGR of 16.3% & to Reach $13.77 Billion By 2018 - New Report by MarketsandMarkets [0] Tools4ever exhibits at Identity Management 2013

... a study by a researcher from University of California, ... are found not in the similarity of the genome ... them. ,Researcher had described genetic differences between the ... that is also expressed in brain cells associated with ...

... be available in pharmacies as over the counter drug ... women to avoid unnecessary pregnancy. The decision was announced// ... the governments decision the minister said, "The step has ... such situations as unprotected sexual exposure, contraceptive accident or ...

... from the Steno Diabetes Center, Denmark has found ... taking //antihypertensive drugs, reduced the chances of developing ... protein in urine of these patients. ... prone to kidney diseases. Supplementation of Spironolactone has ...

... of AIDS and 35 people have died of it in the ... at more than 100 and more than 2,000 full-blown AIDS cases. ... very low awareness in Jharkand. ,Jharkand plans to open ... of HIV spread. This new attempt to open the condom booths ...

... losing their eyesight later in life than non-smokers, says a ... UK with age-related macular degeneration (AMD). Of these, an ... smoking.// ,AMD usually develops after a person reaches ... of the eye. A report by AMD Alliance UK, based ...

... The lancet says that a combination of newer ... procedures.// ,Hypertension is the most important preventable ... the benefits of anti-hypertensive drugs for prevention of ... no individual trial using standard diuretic or Beta-blocker ...

Cached Medicine News:Health News:Indian Health Ministry approves sale of Emergency contraceptives as over the counter drug 2

Human Diseases May Have Clue In Human-Chimp Genome Difference Indian Health Ministry approves sale of Emergency contraceptives as over the counter drug Drug Spironolactone Provides Renal And Cardioprotection In Diabetic Patients Condom vending machine to be started in Jharkand Smokers Face The Risk Of Becoming Blind In Later Life New Drugs For High Blood Pressure Better Than Old Ones

Blunt Weitlaner Retractor....

Weitlaner Beckmann retractor, sharp prongs, SS....

Baby Weitlaner retractor, blunt, 4"....

Scoville sharp curette, 10, straight, scoop size 4 x 10 mm....

Medicine Products:

Blunt Weitlaner Retractor Weitlaner Beckmann Retractor Baby Weitlaner Retractor Scoville Sharp Curette